Harmony Biosciences Files 2024 Annual Report
Ticker: HRMY · Form: 10-K · Filed: Feb 25, 2025 · CIK: 1802665
| Field | Detail |
|---|---|
| Company | Harmony Biosciences Holdings, INC. (HRMY) |
| Form Type | 10-K |
| Filed Date | Feb 25, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
Harmony Biosciences dropped its 2024 10-K. Check financials for FY ending 12/31/24.
AI Summary
Harmony Biosciences Holdings, Inc. filed its 2024 10-K on February 25, 2025, reporting its financial performance for the fiscal year ending December 31, 2024. The company, incorporated in Delaware, operates in the pharmaceutical preparations sector. Key financial details and business operations for the period are outlined in this comprehensive annual report.
Why It Matters
This filing provides investors and stakeholders with a detailed overview of Harmony Biosciences' financial health, strategic initiatives, and risk factors for the past fiscal year, crucial for understanding the company's performance and future outlook.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Harmony Biosciences faces inherent risks related to drug development, regulatory approvals, market competition, and patent expirations.
Key Numbers
- 2024-12-31 — Fiscal Year End (The end date of the reporting period for the 10-K.)
- 2025-02-25 — Filing Date (The date Harmony Biosciences submitted its 10-K to the SEC.)
Key Players & Entities
- Harmony Biosciences Holdings, Inc. (company) — Filer of the 10-K report
- 2024-12-31 (date) — Fiscal year end date
- 2025-02-25 (date) — Filing date of the 10-K
- DE (state) — State of incorporation
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What is the primary business of Harmony Biosciences Holdings, Inc. as indicated in the filing?
The filing indicates Harmony Biosciences Holdings, Inc. operates in the Pharmaceutical Preparations sector, with SIC code 2834.
When did Harmony Biosciences Holdings, Inc. file its 10-K report?
Harmony Biosciences Holdings, Inc. filed its 10-K report on February 25, 2025.
For which fiscal year is this 10-K report?
This 10-K report is for the fiscal year ending December 31, 2024.
In which state was Harmony Biosciences Holdings, Inc. incorporated?
Harmony Biosciences Holdings, Inc. was incorporated in Delaware (DE).
What is the reported business address for Harmony Biosciences Holdings, Inc.?
The business address is 630 W GERMANTOWN PIKE, SUITE 215, PLYMOUTH MEETING, PA 19462.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 25, 2025 regarding Harmony Biosciences Holdings, Inc. (HRMY).